Source:http://linkedlifedata.com/resource/pubmed/id/17615687
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2007-7-9
|
pubmed:abstractText |
Nanoparticle realgar powders (NRP) inhibited U937 cell growth in a time and dose-dependent manner. U937 cells treated with NRP showed typical characteristics of apoptosis including the morphological changes and DNA fragmentation. Caspase family inhibitor (z-VAD-fmk), caspase-8, -9 inhibitor (z-IETD-fmk, Ac-LEHD-CHO, respectively) and caspase-3 inhibitor (z-DEVD-fmk) partially prevented NRP -induced apoptosis. Moreover, the classical substrates of caspase-3, poly-ADP ribose polymerase (PARP) was degraded after U937 cells treatment with NRP. In addition, NRP increased the ratio of Bax/Bcl-2 protein expression. Although p38 inhibitor (SB203580) and ERK inhibitor (PD98059) failed to block cell death, JNK inhibitor (SP600125) had marked inhibitory effects on NRP -induced apoptosis. Furthermore, the phosphorylation of JNK was up-regulated, suggesting that JNK was responsible for NRP -induced apoptosis in U937 cells. These results suggested that the caspase, mitochondria and MAPK signal pathways were involved in NRP-induced U937 apoptosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arsenicals,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/Powders,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfides,
http://linkedlifedata.com/resource/pubmed/chemical/arsenic disulfide,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0253-6269
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
653-8
|
pubmed:meshHeading |
pubmed-meshheading:17615687-Apoptosis,
pubmed-meshheading:17615687-Arsenicals,
pubmed-meshheading:17615687-Caspases,
pubmed-meshheading:17615687-DNA Fragmentation,
pubmed-meshheading:17615687-Dose-Response Relationship, Drug,
pubmed-meshheading:17615687-Humans,
pubmed-meshheading:17615687-MAP Kinase Signaling System,
pubmed-meshheading:17615687-Mitochondria,
pubmed-meshheading:17615687-Nanoparticles,
pubmed-meshheading:17615687-Powders,
pubmed-meshheading:17615687-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:17615687-Signal Transduction,
pubmed-meshheading:17615687-Sulfides,
pubmed-meshheading:17615687-U937 Cells,
pubmed-meshheading:17615687-bcl-2-Associated X Protein
|
pubmed:year |
2007
|
pubmed:articleTitle |
Nanoparticle realgar powders induce apoptosis in U937 cells through caspase MAPK and mitochondrial pathways.
|
pubmed:affiliation |
School of Traditional Chinese Medicines, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
|
pubmed:publicationType |
Journal Article
|